Search details
1.
Engineering the Propeptide of Microbial Transglutaminase Zymogen: Enabling Substrate-Dependent Activation for Bioconjugation Applications.
Bioconjug Chem
; 35(3): 340-350, 2024 Mar 20.
Article
in English
| MEDLINE | ID: mdl-38421254
2.
Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).
Gastric Cancer
; 27(2): 366-374, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38180622
3.
Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study.
Jpn J Clin Oncol
; 54(4): 403-415, 2024 Apr 06.
Article
in English
| MEDLINE | ID: mdl-38251775
4.
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
Int J Clin Oncol
; 29(6): 801-812, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38589679
5.
Design of Protease-Responsive Antifungal Liposomal Formulation Decorated with a Lipid-Modified Chitin-Binding Domain.
Int J Mol Sci
; 25(7)2024 Mar 22.
Article
in English
| MEDLINE | ID: mdl-38612381
6.
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Esophagus
; 2024 Apr 12.
Article
in English
| MEDLINE | ID: mdl-38607538
7.
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
Oncologist
; 28(7): e565-e574, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-35947993
8.
Pharmaceutical Applications of Ionic Liquids: A Personal Account.
Chem Rec
; 23(8): e202300026, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37042429
9.
Preventive effect of dexamethasone premedication on the development of infusion-related reaction in breast cancer patients receiving trastuzumab.
Br J Clin Pharmacol
; 89(7): 2102-2112, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36709967
10.
Molecular crowding elicits the acceleration of enzymatic crosslinking of macromolecular substrates.
Org Biomol Chem
; 21(2): 306-314, 2023 01 04.
Article
in English
| MEDLINE | ID: mdl-36342388
11.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Gastric Cancer
; 26(6): 1020-1029, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37610558
12.
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
Jpn J Clin Oncol
; 53(3): 221-229, 2023 Mar 07.
Article
in English
| MEDLINE | ID: mdl-36533429
13.
Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.
Digestion
; 104(5): 357-369, 2023.
Article
in English
| MEDLINE | ID: mdl-37231829
14.
Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106).
Int J Clin Oncol
; 28(9): 1176-1182, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37418143
15.
Ionic Liquid-Based Green Emulsion Liquid Membrane for the Extraction of the Poorly Soluble Drug Ibuprofen.
Molecules
; 28(5)2023 Mar 03.
Article
in English
| MEDLINE | ID: mdl-36903590
16.
Modification with Conventional Surfactants to Improve a Lipid-Based Ionic-Liquid-Associated Transcutaneous Anticancer Vaccine.
Molecules
; 28(7)2023 Mar 27.
Article
in English
| MEDLINE | ID: mdl-37049732
17.
Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Oncologist
; 27(4): 251-e304, 2022 04 05.
Article
in English
| MEDLINE | ID: mdl-35380725
18.
Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy.
BMC Cancer
; 22(1): 773, 2022 Jul 15.
Article
in English
| MEDLINE | ID: mdl-35840917
19.
Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study.
BMC Cancer
; 22(1): 811, 2022 Jul 23.
Article
in English
| MEDLINE | ID: mdl-35870893
20.
Liposomal Amphotericin B Formulation Displaying Lipid-Modified Chitin-Binding Domains with Enhanced Antifungal Activity.
Mol Pharm
; 19(11): 3906-3914, 2022 11 07.
Article
in English
| MEDLINE | ID: mdl-36066555